Suppr超能文献

[超声泡沫硬化疗法治疗下肢静脉曲张患者病理性反流的早期及长期结果]

[The use of echo-Foam-sclerotherapy for pathological refluxes in patients with lower limb varicose veins: early and long-term results].

作者信息

Belentsov S M

出版信息

Angiol Sosud Khir. 2007;13(2):57-60.

Abstract

The paper presents the results of non-surgical outpatient treatment of 528 patients with lower limb varicose veins (C2-C6 CEAP classes) by echo-Foam-sclerotherapy and compression therapy. Patients were divided into 3 groups (1) patients with vertical veno-venous refluxes: total 315 echo-Foam-sclerotherapy procedures were fulfilled on 202 great saphenous veins (GSV) and 113 lesser saphenous veins (LSV) - occlusion was achieved in 305 cases (96.8%); (2) patients with recurrent varices or after crossectomy (separation of sapheno-popliteal junction): 265 echo-Foam-sclerotherapies on GSVs and/or LSVs - occlusion was achieved in 262 cases (98.9%); (3) 147 thigh or shin incompetent perforating veins - occlusion was achieved in 142 cases (96.6%). Follow-up lasted up to 2 years. Hemodynamically sound recanalization was revealed in 18 (14.4%) from 125 sclerosed veins in the first group; in 1 (2.1%) from 48 veins in the second group and in 5 (10.6%) from 47 perforating veins in the third group. In general, positive long-term effect was achieved in 89.1% cases of echo-Foam-sclerotherapy. In order to assess the feasibility of additional phlebotropic therapy, all patients were divided into the main group, which received Antistax, and control group, which received no venotonics. It was shown that Antistax attenuates main symptoms of chronic venous insufficiency and improves the quality of life.

摘要

本文介绍了采用超声泡沫硬化疗法和压迫疗法对528例下肢静脉曲张患者(C2 - C6 CEAP分级)进行非手术门诊治疗的结果。患者分为3组:(1)存在垂直静脉 - 静脉反流的患者:对202条大隐静脉(GSV)和113条小隐静脉(LSV)共进行了315次超声泡沫硬化治疗,其中305例(96.8%)实现了闭塞;(2)复发性静脉曲张患者或大隐静脉 - 腘静脉交界处离断术后患者:对GSV和/或LSV进行了265次超声泡沫硬化治疗,其中262例(98.9%)实现了闭塞;(3)147条大腿或小腿功能不全的穿通静脉,其中142例(96.6%)实现了闭塞。随访持续了2年。第一组125条硬化静脉中有18条(14.4%)出现血流动力学上良好的再通;第二组48条静脉中有1条(2.1%)出现再通;第三组47条穿通静脉中有5条(10.6%)出现再通。总体而言,超声泡沫硬化疗法89.1%的病例取得了积极的长期效果。为了评估额外进行促静脉回流治疗的可行性,所有患者被分为主要组,接受抗静脉曲张药物Antistax治疗,以及对照组,不接受静脉张力调节药物治疗。结果显示,Antistax可减轻慢性静脉功能不全的主要症状并改善生活质量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验